The ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare Sector

NCT ID: NCT05314530

Last Updated: 2022-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burnout

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Will receive a rehabilitation intervention

Group Type EXPERIMENTAL

ReTA-model

Intervention Type BEHAVIORAL

Validating the rehabilitation model ReTA

Controll

Will receive conventional rehabilitation

Group Type ACTIVE_COMPARATOR

ReTA-model

Intervention Type BEHAVIORAL

Validating the rehabilitation model ReTA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ReTA-model

Validating the rehabilitation model ReTA

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* currently on sick leave for burnout
* employed in the Swedish healthcare services as a nurse or as a physician

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karolinska Institutet

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emma Hagqvist

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emma Hagqvist

Role: PRINCIPAL_INVESTIGATOR

Karolinska Institutet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karolinska Institutet

Stockholm, Outside U.S. and Canada, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emma Hagqvist, PhD

Role: CONTACT

+46730526602

Åke Nygren, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emma Hagqvist, Phd

Role: primary

+46730526602

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ReTA-model

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Written Exposure Therapy for Nurses
NCT06432374 COMPLETED EARLY_PHASE1